Onsdag 23 September | 01:01:25 Europe / Stockholm
Est. tid*
2026-12-15 08:00 Kvartalsrapport 2027-Q2
2026-10-22 N/A X-dag ordinarie utdelning SDOS 0.00 SEK
2026-10-21 N/A Årsstämma
2026-09-17 - Kvartalsrapport 2027-Q1
2026-06-17 - Bokslutskommuniké 2026
2026-06-16 - Extra Bolagsstämma 2027
2026-03-18 - Kvartalsrapport 2026-Q3
2025-12-16 - Kvartalsrapport 2026-Q2
2025-10-24 - X-dag ordinarie utdelning SDOS 0.00 SEK
2025-10-23 - Årsstämma
2025-09-18 - Kvartalsrapport 2026-Q1
2025-06-18 - Bokslutskommuniké 2025
2025-03-12 - Kvartalsrapport 2025-Q3
2024-12-17 - Kvartalsrapport 2025-Q2
2024-10-24 - X-dag ordinarie utdelning SDOS 0.00 SEK
2024-10-23 - Årsstämma
2024-09-18 - Kvartalsrapport 2025-Q1
2024-06-18 - Bokslutskommuniké 2024
2024-03-13 - Kvartalsrapport 2024-Q3
2023-12-12 - Kvartalsrapport 2024-Q2
2023-10-18 - X-dag ordinarie utdelning SDOS 0.00 SEK
2023-10-17 - Årsstämma
2023-09-13 - Kvartalsrapport 2024-Q1
2023-06-15 - Bokslutskommuniké 2023
2023-03-08 - Kvartalsrapport 2023-Q3
2022-12-07 - Kvartalsrapport 2023-Q2
2022-10-18 - X-dag ordinarie utdelning SDOS 0.00 SEK
2022-10-17 - Årsstämma
2022-09-13 - Kvartalsrapport 2023-Q1
2022-06-28 - Bokslutskommuniké 2022
2022-03-11 - Kvartalsrapport 2022-Q3
2021-12-14 - Kvartalsrapport 2022-Q2
2021-10-21 - X-dag ordinarie utdelning SDOS 0.00 SEK
2021-10-20 - Årsstämma
2021-09-23 - Kvartalsrapport 2022-Q1
2021-06-29 - Bokslutskommuniké 2021
2021-03-10 - Kvartalsrapport 2021-Q3
2020-12-16 - Kvartalsrapport 2021-Q2
2020-10-07 - X-dag ordinarie utdelning SDOS 0.00 SEK
2020-10-06 - Årsstämma
2020-09-25 - Kvartalsrapport 2021-Q1
2020-06-26 - Bokslutskommuniké 2020
2020-03-10 - Kvartalsrapport 2020-Q3
2019-12-18 - Kvartalsrapport 2020-Q2
2019-10-09 - X-dag ordinarie utdelning SDOS 0.00 SEK
2019-10-08 - Årsstämma
2019-09-12 - Kvartalsrapport 2020-Q1
2019-06-28 - Bokslutskommuniké 2019
2018-12-14 - Kvartalsrapport 2019-Q2
2018-10-03 - X-dag ordinarie utdelning SDOS 0.00 SEK
2018-10-02 - Årsstämma
2018-06-28 - Bokslutskommuniké 2018
2018-03-22 - Kvartalsrapport 2018-Q3
2017-12-15 - Kvartalsrapport 2018-Q2
2017-10-03 - X-dag ordinarie utdelning SDOS 0.00 SEK
2017-10-02 - Årsstämma
2017-09-29 - Kvartalsrapport 2018-Q1
2017-06-28 - Bokslutskommuniké 2017
2017-03-22 - Kvartalsrapport 2017-Q3
2016-12-15 - Kvartalsrapport 2017-Q2
2016-09-21 - X-dag ordinarie utdelning SDOS 0.00 SEK
2016-09-20 - Årsstämma
2016-09-20 - Kvartalsrapport 2017-Q1
2016-06-30 - Bokslutskommuniké 2016
2016-03-15 - Kvartalsrapport 2016-Q3
2015-12-11 - Kvartalsrapport 2016-Q2
2015-09-24 - X-dag ordinarie utdelning SDOS 0.00 SEK
2015-09-23 - Årsstämma
2015-09-23 - Kvartalsrapport 2016-Q1
2015-06-23 - Bokslutskommuniké 2015
2015-03-26 - Kvartalsrapport 2015-Q3
2014-12-19 - Kvartalsrapport 2015-Q2
2014-10-14 - Årsstämma
2014-09-24 - X-dag ordinarie utdelning SDOS 0.00 SEK
2014-09-23 - Kvartalsrapport 2015-Q1
2014-06-13 - Bokslutskommuniké 2014
LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Scandidos är verksamt inom medicinteknik. Bolaget erbjuder produkter och system för kvalitetssäkring av avancerad strålterapi mot cancer. Systemen analyserar stråldosen inför och under pågående strålbehandling. Bolaget grundades år 2002 och den första produkten lanserades 2006. Sedan starten har Scandidos levererat produkter till strålterapikliniker på global nivå. Huvudkontoret ligger i Uppsala.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Olof Stranding appointed Interim CEO of ScandiDos

2026-09-21 13:30:00

ScandiDos AB announces that Olof Stranding has been appointed Interim CEO of ScandiDos, effective 21 September 2026.

Olof Stranding is based in Uppsala and brings extensive experience from senior leadership positions, including as CFO and CEO of listed technology companies, most recently as CEO of Acuvi AB, listed on Nasdaq First North. Olof holds a degree in Business and Economics from Uppsala University and succeeds Anders Murman, who has acted as Acting CEO since 6 May. Anders will leave the company no later than 31 December 2026 to pursue new challenges.

“Olof Stranding’s solid experience as both CFO and CEO in technology companies makes him well suited for this role. The Board is appointing an Interim CEO for twelve to eighteen months to drive the change programme and strengthen profitability, while giving us time to conduct a thorough recruitment process for a permanent CEO. The Board also wishes to extend its sincere thanks to Anders Murman for his contribution as Acting CEO,” says Fredrik Ljungberg, Chairman of the Board.

“ScandiDos has strong products and a well-regarded brand. I look forward to getting to know the business closely and, together with the employees and the Board, contributing my experience to strengthen the company’s commercial focus and build sustainable, profitable growth,” says Olof Stranding.

“I am proud of what we have achieved together during this period, and I look forward to continued good cooperation with Olof and the rest of the team for the remainder of the year,” says Anders Murman.

For further information, please contact: Fredrik Ljungberg, Chairman of the Board, fredrik.ljungberg@rtigroup.com, +44 7485 247 154

About ScandiDos
ScandiDos is an innovative forward-thinking company with groundbreaking software and hardware solutions for patient quality assurance in modern radiation therapy. Our Delta4 Family of products delivers a comprehensive QA solution, making the treatment process safe and efficient. We reinforce the confidence in radiotherapy clinics by providing professionals at the clinics with power and performance through independent QA.

The head office is in Uppsala Science Park, where product development is carried out. Sales are carried out by sales offices in the USA, Malaysia, and France, directly in the Nordic countries and through distributors in over 50 countries.
ScandiDos is listed on NASDAQ First North Stockholm with the ticker code SDOS. Certified Adviser is Tapper Partners AB. Additional investor information can be found at Scandidos.com. Product information can be found on Delta4family.com